Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.700
-0.020 (-0.74%)
Aug 11, 2025, 10:58 AM - Market open
Aspen Technology Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$8.17
Upside
+202.59%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +196.30% | Jul 11, 2025 |
Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +196.30% | Jul 1, 2025 |
Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +196.30% | Jun 10, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +307.41% | Jun 3, 2025 |
Needham | Needham | Strong Buy Reiterates $6 → $8 | Strong Buy | Reiterates | $6 → $8 | +196.30% | Jun 2, 2025 |
JMP Securities | JMP Securities | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +122.22% | May 29, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +233.33% | May 29, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +233.33% | May 16, 2025 |
JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +85.19% | Apr 28, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +159.26% | Apr 28, 2025 |
Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +122.22% | Apr 10, 2025 |
Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +122.22% | Feb 27, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +159.26% | Feb 26, 2025 |
Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +122.22% | Jan 6, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +196.30% | Nov 15, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +159.26% | Nov 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.